No. To manufacture the drug cost very little in comparison to the research put into development and getting the drug through the lengthy FDA trials. That is why it makes no sense to discontinue the drug. The cost has already been paid. People still buy (at $200 a bottle) and use Avodart, even with generics, and the cost to manufacture is similar to generics. So it is in GSK's best interest to continue to manufacture the drug because it is profitable to do so.
Also, I emailed GSK and got a response. No discontinuation of Avodart. Either you are trolling, or your pharmacy is really sketchy. If you are not a troll, find another pharmacy asap.
View attachment 120596